Pathophysiological Consequences of Neuronal α-Synuclein Overexpression: Impacts on Ion Homeostasis, Stress Signaling, Mitochondrial Integrity, and Electrical Activity

α-Synuclein (α-Syn) is intimately linked to the etiology of Parkinson's Disease, as mutations and even subtle increases in gene dosage result in early onset of the disease. However, how this protein causes neuronal dysfunction and neurodegeneration is incompletely understood. We thus examined a comprehensive range of physiological parameters in cultured rat primary neurons overexpressing α-Syn at levels causing a slowly progressive neurodegeneration. In contradiction to earlier reports from non-neuronal assay systems we demonstrate that α-Syn does not interfere with essential ion handling capacities, mitochondrial capability of ATP production or basic electro-physiological properties like resting membrane potential or the general ability to generate action potentials. α-Syn also does not activate canonical stress kinase Signaling converging on SAPK/Jun, p38 MAPK or Erk kinases. Causative for α-Syn-induced neurodegeneration are mitochondrial thiol oxidation and activation of caspases downstream of mitochondrial outer membrane permeabilization, leading to apoptosis-like cell death execution with some unusual aspects. We also aimed to elucidate neuroprotective strategies counteracting the pathophysiological processes caused by α-Syn. Neurotrophic factors, calpain inhibition and increased lysosomal protease capacity showed no protective effects against α-Syn overexpression. In contrast, the major watchdog of outer mitochondrial membrane integrity, Bcl-Xl, was capable of almost completely preventing neuron death, but did not prevent mitochondrial thiol oxidation. Importantly, independent from the quite mono-causal induction of neurotoxicity, α-Syn causes diminished excitability of neurons by external stimuli and robust impairments in endogenous neuronal network activity by decreasing the frequency of action potentials generated without external stimulation. This latter finding suggests that α-Syn can induce neuronal dysfunction independent from its induction of neurotoxicity and might serve as an explanation for functional deficits that precede neuronal cell loss in synucleopathies like Parkinson's disease or dementia with Lewy bodies.

[1]  Roger D. Traub,et al.  Aberrant Network Activity in Schizophrenia , 2017, Trends in Neurosciences.

[2]  F. Antunes,et al.  Quantitative biology of hydrogen peroxide signaling , 2017, Redox biology.

[3]  M. Havlík,et al.  From Anomalies to Essential Scientific Revolution? Intrinsic Brain Activity in the Light of Kuhn's Philosophy of Science , 2017, Front. Syst. Neurosci..

[4]  D. James Surmeier,et al.  Selective neuronal vulnerability in Parkinson disease , 2017, Nature Reviews Neuroscience.

[5]  Guanghui Wang,et al.  Mitochondrial dysfunction in Parkinson’s disease , 2016, Translational Neurodegeneration.

[6]  J. Sachs,et al.  Membrane remodeling and mechanics: Experiments and simulations of α-Synuclein. , 2016, Biochimica et biophysica acta.

[7]  R. Kriwacki,et al.  Discoveries and controversies in BCL‐2 protein‐mediated apoptosis , 2016, The FEBS journal.

[8]  C. Dobson,et al.  Ca2+ is a key factor in α-synuclein-induced neurotoxicity , 2016, Journal of Cell Science.

[9]  Yaling Shi,et al.  Saikosaponin-D Reduces H2O2-Induced PC12 Cell Apoptosis by Removing ROS and Blocking MAPK-Dependent Oxidative Damage , 2016, Cellular and Molecular Neurobiology.

[10]  K. Lapidus,et al.  The Significance of the Default Mode Network (DMN) in Neurological and Neuropsychiatric Disorders: A Review , 2016, The Yale journal of biology and medicine.

[11]  Alessandro Gozzi,et al.  Large-scale functional connectivity networks in the rodent brain , 2016, NeuroImage.

[12]  H. Braak,et al.  Review: Sporadic Parkinson's disease: development and distribution of α‐synuclein pathology , 2016, Neuropathology and applied neurobiology.

[13]  D. Selkoe,et al.  New insights into cellular α-synuclein homeostasis in health and disease , 2016, Current Opinion in Neurobiology.

[14]  P. Gubellini,et al.  Animal models of Parkinson's disease: An updated overview. , 2015, Revue neurologique.

[15]  C. Scavone,et al.  Suppression of MAPK attenuates neuronal cell death induced by activated glia-conditioned medium in alpha-synuclein overexpressing SH-SY5Y cells , 2015, Journal of Neuroinflammation.

[16]  M. Raichle The brain's default mode network. , 2015, Annual review of neuroscience.

[17]  Richard Wade-Martins,et al.  Mitochondrial dysfunction and mitophagy in Parkinson's: from familial to sporadic disease. , 2015, Trends in biochemical sciences.

[18]  P. Spano,et al.  Mitochondrial Dysfunction and α-Synuclein Synaptic Pathology in Parkinson's Disease: Who's on First? , 2015, Parkinson's disease.

[19]  David F. Meaney,et al.  Automated quantification of neuronal networks and single-cell calcium dynamics using calcium imaging , 2015, Journal of Neuroscience Methods.

[20]  L. Aguayo,et al.  Extracellular α‐synuclein alters synaptic transmission in brain neurons by perforating the neuronal plasma membrane , 2015, Journal of neurochemistry.

[21]  D. Green,et al.  The DNA-binding domain mediates both nuclear and cytosolic functions of p53 , 2014, Nature Structural &Molecular Biology.

[22]  M. Brini,et al.  Calcium signaling in Parkinson’s disease , 2014, Cell and Tissue Research.

[23]  A. Brice,et al.  Mitochondrial dysfunctions in Parkinson's disease. , 2014, Revue neurologique.

[24]  S. Kügler,et al.  Metabolic differences in hippocampal ‘Rett’ neurons revealed by ATP imaging , 2014, Molecular and Cellular Neuroscience.

[25]  S. Pouvreau,et al.  Genetically encoded reactive oxygen species (ROS) and redox indicators , 2014, Biotechnology journal.

[26]  Richard Wade-Martins,et al.  Deficits in dopaminergic transmission precede neuron loss and dysfunction in a new Parkinson model , 2013, Proceedings of the National Academy of Sciences.

[27]  Jasper Akerboom,et al.  β‐synuclein aggregates and induces neurodegeneration in dopaminergic neurons , 2013, Annals of neurology.

[28]  Stefan R. Pulver,et al.  Genetically encoded calcium indicators for multi-color neural activity imaging and combination with optogenetics , 2013, Front. Mol. Neurosci..

[29]  E. Cadenas,et al.  Mitochondrial thiols in the regulation of cell death pathways. , 2012, Antioxidants & redox signaling.

[30]  A. Björklund,et al.  α-Synuclein–Induced Down-Regulation of Nurr1 Disrupts GDNF Signaling in Nigral Dopamine Neurons , 2012, Science Translational Medicine.

[31]  Fabrizio Esposito,et al.  Default-mode network connectivity in cognitively unimpaired patients with Parkinson disease , 2012, Neurology.

[32]  L. Opitz,et al.  Oxidative burden and mitochondrial dysfunction in a mouse model of Rett syndrome , 2012, Neurobiology of Disease.

[33]  S. Kügler,et al.  Calpastatin-mediated inhibition of calpains in the mouse brain prevents mutant ataxin 3 proteolysis, nuclear localization and aggregation, relieving Machado-Joseph disease. , 2012, Brain : a journal of neurology.

[34]  S. Kügler,et al.  Aggregation of αSynuclein promotes progressive in vivo neurotoxicity in adult rat dopaminergic neurons , 2011, Acta Neuropathologica.

[35]  P. Blain,et al.  Mitochondrial Dysfunction in Parkinson's Disease , 2011, Parkinson's disease.

[36]  S. Kügler,et al.  CNS-expressed cathepsin D prevents lymphopenia in a murine model of congenital neuronal ceroid lipofuscinosis. , 2010, The American journal of pathology.

[37]  K. Unsicker,et al.  ERK and cell death: ERK1/2 in neuronal death , 2010, The FEBS journal.

[38]  M. Dallas,et al.  α‐Synuclein modulation of Ca2+ signaling in human neuroblastoma (SH‐SY5Y) cells , 2009, Journal of neurochemistry.

[39]  E. Erdfelder,et al.  Statistical power analyses using G*Power 3.1: Tests for correlation and regression analyses , 2009, Behavior research methods.

[40]  H. Jäckle,et al.  Pre‐fibrillar α‐synuclein variants with impaired β‐structure increase neurotoxicity in Parkinson's disease models , 2009, The EMBO journal.

[41]  Takeharu Nagai,et al.  Visualization of ATP levels inside single living cells with fluorescence resonance energy transfer-based genetically encoded indicators , 2009, Proceedings of the National Academy of Sciences.

[42]  S. Kügler,et al.  Remodelling of the respiratory network in a mouse model of Rett syndrome depends on brain‐derived neurotrophic factor regulated slow calcium buffering , 2009, The Journal of physiology.

[43]  V. Vingtdeux,et al.  Calcium signaling in neurodegeneration , 2009, Molecular Neurodegeneration.

[44]  N. Danial,et al.  Bad targets the permeability transition pore independent of Bax or Bak to switch between Ca2+-dependent cell survival and death. , 2009, Molecular cell.

[45]  A. Paetau,et al.  Cathepsin D expression level affects alpha-synuclein processing, aggregation, and toxicity in vivo , 2009, Molecular Brain.

[46]  V. Buchman,et al.  Modulation of α-synuclein expression in transgenic animals for modelling synucleinopathies — is the juice worth the squeeze? , 2008, Neurotoxicity Research.

[47]  M. Mattson,et al.  Calcium and neurodegeneration , 2007, Aging cell.

[48]  S. Dudek,et al.  Differential activation of extracellular signal-regulated kinase 1 and a related complex in neuronal nuclei , 2006, Brain cell biology.

[49]  Qing Zhao,et al.  Cytochrome c acts as a cardiolipin oxygenase required for release of proapoptotic factors , 2005, Nature chemical biology.

[50]  C. Griesinger,et al.  Release of long-range tertiary interactions potentiates aggregation of natively unstructured alpha-synuclein. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[51]  R. Tsien,et al.  Imaging Dynamic Redox Changes in Mammalian Cells with Green Fluorescent Protein Indicators* , 2004, Journal of Biological Chemistry.

[52]  Devin Oglesbee,et al.  Investigating Mitochondrial Redox Potential with Redox-sensitive Green Fluorescent Protein Indicators* , 2004, Journal of Biological Chemistry.

[53]  S. Kügler,et al.  Differential transgene expression in brain cells in vivo and in vitro from AAV-2 vectors with small transcriptional control units. , 2003, Virology.

[54]  S. Harper,et al.  MAPKs: new targets for neurodegeneration , 2003, Expert opinion on therapeutic targets.

[55]  P. Lansbury,et al.  Alpha-synuclein, especially the Parkinson's disease-associated mutants, forms pore-like annular and tubular protofibrils. , 2002, Journal of molecular biology.

[56]  V. Subramaniam,et al.  Dependence of α-synuclein aggregate morphology on solution conditions , 2002 .

[57]  Sten Orrenius,et al.  Cytochrome c release from mitochondria proceeds by a two-step process , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[58]  I. Kanazawa,et al.  α-Synuclein Affects the MAPK Pathway and Accelerates Cell Death* , 2001, The Journal of Biological Chemistry.

[59]  S. Kügler,et al.  Neuron-Specific Expression of Therapeutic Proteins: Evaluation of Different Cellular Promoters in Recombinant Adenoviral Vectors , 2001, Molecular and Cellular Neuroscience.

[60]  B. Hille,et al.  Mitochondrial oversight of cellular Ca2+ signaling , 1998, Current Opinion in Neurobiology.

[61]  S. R. Datta,et al.  Akt Phosphorylation of BAD Couples Survival Signals to the Cell-Intrinsic Death Machinery , 1997, Cell.

[62]  S. Grzesiek,et al.  NMRPipe: A multidimensional spectral processing system based on UNIX pipes , 1995, Journal of biomolecular NMR.

[63]  F S Fay,et al.  Imaging in five dimensions: time-dependent membrane potentials in individual mitochondria. , 1993, Biophysical journal.

[64]  C. Thompson,et al.  bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death , 1993, Cell.

[65]  T. Murphy,et al.  Spontaneous synchronous synaptic calcium transients in cultured cortical neurons , 1992, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[66]  L M Loew,et al.  Membrane potential can be determined in individual cells from the nernstian distribution of cationic dyes. , 1988, Biophysical journal.

[67]  A. Giese,et al.  Interaction of α-synuclein with biomembranes in Parkinson's disease--role of cardiolipin. , 2016, Progress in lipid research.

[68]  B. Kagan Membrane pores in the pathogenesis of neurodegenerative disease. , 2012, Progress in molecular biology and translational science.

[69]  S. Remington,et al.  Redox-sensitive green fluorescent protein: probes for dynamic intracellular redox responses. A review. , 2008, Methods in molecular biology.

[70]  W. N. Ross,et al.  Changes in intracellular calcium during neuron activity. , 1989, Annual review of physiology.